Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Pari Pharma GmbH
Related studies linked through entity extraction aliases.
Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)
- Status
- TERMINATED
- Phase
- PHASE3
L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3